ArticleScientific reports2017
A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles.
Flávia Sousa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled itcites it